GlassScriptPhysician profile
Joseph Rangel
NPI 1093240269
$825.45
in general payments reported to CMS, 2019-2025
10 companies · $347 in 2025
The $347 reported for 2025 was more than what 88% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.92 · 2021: $89.67 · 2022: $175 · 2023: $151 · 2024: $49.24 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $275.78 | 2020-2023 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Collegium Pharmaceutical, INC. | $209.69 | 2025 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $111.40 | 2021-2025 | Qelbree, Qelbree |
| Sanofi Pasteur INC. | $73.77 | 2022-2023 | |
| Cranial Technologies, INC | $42.09 | 2023-2025 | Doc Band |
| Alk-Abello, INC | $33.14 | 2025 | Ragwitek, Odactra, Grastek |
| Verrica Pharmaceuticals INC. | $29.24 | 2024 | Ycanth |
| Corium, LLC | $21.12 | 2022 | |
| Lnhc, INC | $15.67 | 2025 | Zelsuvmi |
| Glaxosmithkline, LLC. | $13.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Rangel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.